Viewing Study NCT03905135

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:43 PM
Ignite Modification Date: 2026-02-11 @ 7:48 PM
Study NCT ID: NCT03905135
Status: COMPLETED
Last Update Posted: 2022-09-13
First Post: 2019-04-03
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Interleukin-15 (IL-5) in Combination With Avelumab (Bavencio) in Relapsed/Refractory Mature T-cell Malignancies
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Peripheral T-cell Lymphoma NOS View
None Mycosis Fungoides View
None Sezary Syndrome View
None Anaplastic Large Cell Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None T-cell Lymphoproliferative Disorder View
None Cutaneous T-Cell Lymphoma View
None Anti-PD-L1 monoclonal antibody View
None Antibody Dependent Cellular Cytotoxicity (ADCC) View